CATTLE RAISERS COMMUNITY
INDUSTRY ALLIED
Elanco Receives USDA Approval for Vaccine
OF THE
ANGUS SPECIAL SECTION
If you have Angus bulls or females for sale,
The Cattleman will take your message to 20,000 readers in February.
Be part of the Angus special advertising section in the February issue of
The Cattleman magazine.
FEATURES OF THIS SPECIAL ADVERTISING SECTION
• Highlights of the Angus community • Upcoming Angus events
Contact Shawn McCoy, 800-242-7820, ext. 121
to be part of The Cattleman’s Angus Special Advertising section
DEADLINE TO RESERVE SPACE IS DECEMBER 30
T
HE U.S. DEPARTMENT OF AGRICUL- ture (USDA) has issued the
Veterinary Biological License for Viralign 6®, the fi rst combination modified-live virus (MLV) vac- cine to provide targeted protection against bovine viral diarrhea (BVD) virus 1b — the most predominant BVD virus strain in the U.S. Marketed by Elanco, Viralign
6 also provides protection against BVD viral strains 1a and 2, bovine respiratory syncytial virus (BRSV), infectious bovine rhinotracheitis (IBR) virus and parainfluenza3 (PI3) virus. This fi rst-of-its-kind vaccine en-
ables low-volume, subcutaneous administration in cattle 5 months of age or older. “Even though producers have
vaccinated for the BVD virus for years, research shows its incidence has not gone down, and 1b has re- placed 1a as the most predominant BVD strain,” says Carl Guthrie, D.V.M. and director of Elanco beef technical services. “The good news is that ongoing vaccination pro- grams appear to have decreased the predominance of 1a in the U.S. But, it also suggests current modifi ed- live 1a vaccines may not adequately protect calves from 1b infections. Since BVD is the most costly vi- ral disease in cattle, Viralign 6 is an important herd-health tool that will help combat all 3 major BVD strains.”
28 The Cattleman December 2013
thecattlemanmagazine.com
BE A PART
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100